South America Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Protein

South America Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)

The South America pharmaceutical excipients market is expected to grow from US$ 348.40 million in 2022 to US$ 526.54 million by 2028. It is estimated to register a CAGR of 7.1% from 2022 to 2028.

Rising Demand and Emphasis on Co-Processed Excipients is fueling the growth of South America pharmaceutical excipients market

Formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain APIs to be manufactured adequately. These scientists focus on producing co-processed and multifunctional excipients with enhanced performance. Co-processed excipients are a mixture of two or more existing excipients at the sub-particle level, offering substantial benefits of the incorporated excipients and minimizing their drawbacks. These multipurpose excipients have dramatically reduced the number of incorporating excipients in the tablet. The co-processed excipients are used to improve the drug's flow, disintegration, lubrication, and compressibility. The excipients also simplify the formulation process and make it cost-effective. They are increasingly used to convert complicated and labor-intensive formulation processes, such as wet granulation, to quick direct-compression processes, without affecting the final product quality or performance. Co-processed excipients play a crucial role in creating a stable, result-oriented drug delivery system with enhanced chemical, physical, and mechanical properties. The companies are focusing on developing co-processed excipients for drug formulations. For instance, in July 2021, DFE Pharma launched a co-processed excipient, Pharmacel sMCC 90, silicified microcrystalline cellulose (MCC). It has been developed as the synergistic solution for challenging oral solid dosage formulations. A co-processed excipient is a promising tool in the production of pharmaceutical products. Existing co-processed adjuvants cannot fulfill all the needs for the preparation of various novel formulations. There is also enough space for the production of new co-processed excipients to satisfy the demand of the pharmaceutical industries, which is expected to act as an opportunity for the growth of the South America pharmaceutical excipients market during the forecast period.

South America Pharmaceutical Excipients Market Overview

South America includes Argentina and Brazil. The pharmaceutical excipients market in the region is expected to have growth opportunities in both countries. Growing geriatric population in both countries and increasing prevalence of chronic diseases are driving the market. Moreover, developments in the healthcare industry and a rise in research and development in the pharmaceutical sector are likely to foster the market’s growth during the forecast period. Hence, the need for functional excipients is growing across the country, driving the pharmaceutical excipients market in the country. Brazil is the fifth-largest country globally by area and population. The country is experiencing the fastest demographic aging and a rise in the prevalence of noncommunicable Diseases (NCD), which is expected to serve wider growth opportunities for the market. For instance, in 2020, the elderly population accounted for 30.1 million, about 14.3% of the population. In addition, as per the Brazil Statistical Institute, people aged 65 and above are expected to reach 36% by 2050. As the geriatric population in Brazil grows, it leads to an increased incidence of various health illnesses such as lifestyle heart disorders and other cardiovascular diseases, which may lead to increased morbidities and demand for services in the healthcare system. Most companies are increasing their presence in the Brazilian market to capture the significant potential available in the pharmaceutical excipients market.

South America Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)

South America Pharmaceutical Excipients Market Segmentation

The South America pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country. Based on type, the South America pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The plant protein & polyols & cyclodextrins segment registered the largest market share in 2022.

Based on clinical indication, the South America pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.

Based on functionality, the South America pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.

Based on application, the South America pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.

Based on end user, the South America pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.

Based on country, the South America pharmaceutical excipients market is segmented into Brazil, Argentina, and the Rest of South America. Saudi Arabia dominated the market in 2022.

Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the South America pharmaceutical excipients market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America pharmaceutical excipients market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South America pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South America market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.